# 106 - biomolecules-11-01518 processing report

## Lifecycle status

**PASS**

**OVERRIDEN BY CONNOR FOWLER ON 2026-08-26T07:36:18Z**

**HUMAN REVIEW HAS YIELDED SUFFICIENT EVIDENCE TO PASS THIS PACKET**


The primary source is usable and the ATOM/SEA repair now passes its artifact and validation gates. The packet cannot be promoted because downstream reference-processing completion is not proven. The folder remains Active; no move to Processed or Needs Resolution was performed.

## Source inventory and identity

- Packet folder: `106 - biomolecules-11-01518`
- Packet Drive ID: `183Zu__IQa7w_zF98o2GjiWHaCe_peNFM`
- Primary source: `biomolecules-11-01518.pdf`
- Primary Drive ID: `1KCMtLTndfeWqevwIe4dNWG-tsxVoMMvP`
- Primary file size: 8,958,963 bytes
- PDF pages: 34
- SHA-256: `a09b9e8e76b13d905c3eaffe00dad1a2a4888fdadd9b34af747b6f6f49bfd5f9`
- Exact title: *Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation*
- Authors: Andreia Marinho; Cláudia Nunes; Salette Reis
- Source: Biomolecules. 2021;11:1518
- DOI: `10.3390/biom11101518`
- Publication date: 2021-10-15
- Source type: narrative review
- Separate supplements in packet: none
- PDF attachments: none
- Primary-source usability: PASS

The packet contained only the primary PDF. The PDF is readable, structurally intact, and suitable for extraction. The article identity in the PDF matches the DOI and title used by every regenerated artifact.

## Pre-repair artifact audit

The packet and the Clin Med Pharm GitHub Sync JSON, HTML, and Markdown output folders were searched using exact title, DOI, journal/article identity, stable source metadata, and content. No identity-matched ATOM JSON, validation JSON, coverage JSON, SEA HTML, reference-processing Markdown, or processing report was found before repair. Unrelated hyaluronic-acid outputs were not accepted by filename or topic similarity.

No prior ATOM validation report existed for this source, so there was no reconstructed/local validator result to inherit. Authoritative validation was run directly against the supplied governing files.

## ATOM repair and validation

- Shared publication ID: `9a202a7d-8f46-5f9d-af7c-dc9085d1c089`
- Atoms: 44
- Atom kinds: 34 `other`, 4 `limitation`, 3 `author_conclusion`, 1 `study_objective`, 1 `funding_disclosure`, 1 `conflict_of_interest`
- Assertion origin: 44 `normalized_from_source`
- Review status: `needs_review` for all model-extracted atoms
- Unique atom IDs: PASS
- Shared publication identity: PASS
- Exact duplicate statement/anchor pairs: 0

Because the source is a narrative review, findings from cited experiments were not represented as if this paper generated primary participant data. Secondary study reports use `atom_kind="other"` with tags such as `secondary_reported_result`. Bibliography entries were not atomized.

Validation order and result:

1. `literature(1).py` Pydantic structural validation: **PASS**, 0 errors
2. `literature_atom.schema.json` JSON Schema validation: **PASS**, 0 errors
3. `literature_atoms(1).py` atom-kind sufficiency validation: **PASS**, 0 errors, 0 warnings

Direct semantic checks passed for the review objective/conclusion, numerical biological claims, explicit delivery limitations, and table-derived evidence patterns. Source anchors retain section plus page and, when reliable text extraction allowed, exact supporting excerpts. Eight atoms use section-plus-page/paragraph anchoring without a verbatim excerpt because PDF text-layer column ordering interrupted a clean continuous excerpt; their page locations were directly reconciled to the corresponding source sections.

## SEA repair and QA

The SEA was regenerated from the same PDF/hash used for ATOM.

Coverage:

- PDF pages rendered and inspected: 34/34
- Main figures: 3/3 reconciled
  - Figure 1: HA chemical structure
  - Figure 2: synthesis by HAS-1/HAS-2/HAS-3
  - Figure 3: enzymatic and ROS degradation
- Main tables: 4/4 reconciled
  - Table 1: 20 OA formulation/study rows, pages 12-13
  - Table 2: 12 RA formulation/study rows, page 16
  - Table 3: 5 wound-healing rows, page 21
  - Table 4: 6 IBD rows, page 23
- Algorithms/workflows: 0
- Separate supplements: 0
- Bibliography: 173 references, handled separately

SEA mechanical QA:

- Self-contained HTML: PASS
- HTML parseability: PASS
- TOC targets: PASS
- Source metadata and DOI: PASS
- Internal chat/file citation syntax: absent
- TODO/placeholders/planning language: absent
- Required appraisal dimensions: present and scored after extraction

Semantic spot checks:

- Primary conclusion: PASS — the SEA preserves both the authors' promising interpretation and the explicit delivery limitations.
- Numerical claim: PASS — source magnitudes such as HMWHA >1000 kDa, compartment-specific half-lives, and up to 10,000× water binding are preserved as review-level synthesis rather than primary-study data.
- Limitation/uncertainty: PASS — short biological-fluid half-life, possible crosslinking toxicity, viscosity, and need for further study are represented.
- Figure/table-derived claim: PASS — all four table row sets and all three main figures are reconciled.

Appraisal verdict: **Skim deeply.** The source is useful for mechanistic orientation, formulation mapping, and citation discovery, but its narrative-review methods and heterogeneous secondary evidence do not support direct treatment selection.

## ATOM/SEA reconciliation

ATOM and SEA use the same exact title, DOI, source Drive ID, SHA-256, and publication identity. The central mechanistic claims, molecular-weight distinctions, disease-application synthesis, delivery limitations, and visual/table evidence were compared across both outputs. No consequential cross-artifact contradiction or source-version mismatch was found.

## Reference-processing verification

The article bibliography contains 173 numbered references and was transferred completely to the reference task queue with numbering 1 through 173 reconciled.

A queue existing is not treated as completion. No pre-existing identity-matched reference-processing register for this packet was found. Representative Drive searches for cited studies including reference 80 (liposomal celecoxib-hyaluronate for OA), reference 101 (HA-coated solid lipid nanoparticles for RA), and reference 140 (HA plus mesalamine in experimental IBD) returned the review itself rather than defensible downstream lifecycle-completion evidence for those cited publications.

Therefore reference-processing completion remains **NOT PROVEN**. All 173 queue entries remain unchecked pending identity-matched disposition against the live TBR/Active/Processed/Citation Bank convention.

## Output locations

### GitHub Sync / Literature Review / Outputs / Clin Med Pharm / JSON

- `106-biomolecules-11-01518-atoms.json` — Drive ID `1-7hODC4T2B_Hc1O3YoygvE_IixTAvHPN`
- `106-biomolecules-11-01518-validation.json` — Drive ID `1WtmdSL-Vh-L8UrO8GptSIKmumnfuroyY`
- `106-biomolecules-11-01518-coverage.json` — Drive ID `1saTiStFG5pVn2dFnRz4K1WPcENjrFgwS`

### GitHub Sync / Literature Review / Outputs / Clin Med Pharm / HTML

- `106-biomolecules-11-01518-sea.html` — Drive ID `1hUCPIYeXmRGkokLq66kLnHoLUvjvughV`

### GitHub Sync / Literature Review / Outputs / Clin Med Pharm / MD

- `106-biomolecules-11-01518-reference-task-queue.md` — Drive ID `1q4Ji19r4TGVN7WyB6JUaU5lptsUkqYwf`
- `106-biomolecules-11-01518-processing-report.md` — this report

Uploaded ATOM, validation, coverage, SEA, and reference-queue copies were read back from Drive and matched the intended source identity.

## Governing sources

ATOM validation and serialization followed the supplied project sources in authority order: `literature(1).py`, `literature_atoms(1).py`, `literature_atom.schema.json`, `README(2).md`, then `example_atom(1).json` as illustrative only. `large-source-ATOM-SEA.md` supplied supporting coverage and secondary-source guardrails.

SEA used `summary-evaluation-appraisal-protocol-v4-compact.md` as the governing project protocol. `summary-evaluation-appraisal-protocol-v3-compact.html` was historical reference only.

External web access was used only to invoke PDF-viewing verification against the publisher-hosted copy. The extraction, validation, semantic checks, and appraisal are grounded in the Google Drive PDF.

## Lifecycle action

**No move performed.** `106 - biomolecules-11-01518` remains in Active Clinical Medicine & Pharmacy. It was not moved to Needs Resolution because the primary source is usable and its identity is clear.

## Exact remaining task

Reconcile references 1 through 173 in `106-biomolecules-11-01518-reference-task-queue.md` against the live project literature lifecycle, and record a defensible completed/disposition state for each cited publication. After all 173 entries have verified lifecycle outcomes, rerun the packet closure gate. Move the packet to `90 - Processed` only if the reference gate passes and the current ATOM/SEA artifacts still pass identity, validation, coverage, and semantic checks.
